Gene · 220
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers. | Cancers (Basel) | 2024 | 39001459 | PubTator, text mining | PubMed |
| Identification of Novel Isatin Derivative Bearing a Nitrofuran Moiety as Potent Multi-Isoform Aldehyde Dehydrogenase Inhibitor. | Molecules | 2024 | 38999066 | PubTator, text mining | PubMed |
| Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer. | Cancer Res Commun | 2024 | 38669046 | PubTator, text mining | PubMed |
| Burn Pit Smoke Condensate-Mediated Toxicity in Human Airway Epithelial Cells. | Chem Res Toxicol | 2024 | 38652897 | PubTator, text mining | PubMed |
| Homeostatic status of thyroid hormones and brain water movement as determinant factors in biology of cerebral gliomas: a pilot study using a bioinformatics approach. | Front Neurosci | 2024 | 38476871 | PubTator, text mining | PubMed |
| Histone H3K36me3 mediates the genomic instability of Benzo[a]pyrene in human bronchial epithelial cells. | Environ Pollut | 2024 | 38367693 | PubTator, text mining | PubMed |
| Gut Microbiome Mediates Ferroptosis Resistance for Colorectal Cancer Development. | Cancer Res | 2024 | 38276975 | PubTator, text mining | PubMed |
| CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review. | Biomedicines | 2024 | 38275409 | PubTator, text mining | PubMed |
| m6A modification mediates SLC3A2/SLC7A5 translation in 3-methylcholanthrene-induced uroepithelial transformation. | Cell Biol Toxicol | 2024 | 38267663 | PubTator, text mining | PubMed |
| Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice. | Medicina (Kaunas) | 2024 | 38256428 | PubTator, text mining | PubMed |
| Omics Studies of Tumor Cells under Microgravity Conditions. | Int J Mol Sci | 2024 | 38255998 | PubTator, text mining | PubMed |
| Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach. | Biomolecules | 2024 | 38254687 | PubTator, text mining | PubMed |
| Molecular Insights into the Breast and Prostate Cancer Cells in Response to the Change of Extracellular Zinc. | J Oncol | 2024 | 38249992 | PubTator, text mining | PubMed |
| The implications for urological malignancies of non-coding RNAs in the the tumor microenvironment. | Comput Struct Biotechnol J | 2024 | 38249783 | PubTator, text mining | PubMed |
| Permanent neonatal diabetes-causing insulin mutations have dominant negative effects on beta cell identity. | Mol Metab | 2024 | 38237895 | PubTator, text mining | PubMed |
| Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma. | Neoplasia | 2024 | 38237304 | PubTator, text mining | PubMed |
| Maternally Inherited Essential Hypertension May Be Associated with the Mutations in Mitochondrial tRNAGlu Gene. | Pharmgenomics Pers Med | 2024 | 38222291 | PubTator, text mining | PubMed |
| Retinoic acid signaling regulates spatiotemporal specification of human green and red cones. | PLoS Biol | 2024 | 38206904 | PubTator, text mining | PubMed |
| Transforming Growth Factor-β/Smad Signaling Inhibits Melanoma Cancer Stem Cell Self-Renewal, Tumor Formation and Metastasis. | Cancers (Basel) | 2024 | 38201651 | PubTator, text mining | PubMed |
| Mutual regulation of PD-L1 immunosuppression between tumor-associated macrophages and tumor cells: a critical role for exosomes. | Cell Commun Signal | 2024 | 38195554 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/220/papers?page=6